Cure SMA Growth, Revenue, Number of Employees and Funding

Overview

Location:
Chicago, IL USA
Total Funding:N/A
Industry:NonProfit
Founded:1984
Lead Investor(s):N/A
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Cure SMA's estimated revenue is currently $12.1M per year.
  • Cure SMA's estimated revenue per employee is $98049

Employee Data

  • Cure SMA has 123 Employees.
  • Cure SMA grew their employee count by 31% last year.
  • Cure SMA currently has 1 job openings.

What Is Cure SMA?

Cure SMA is dedicated to the treatment and cure of spinal muscular atrophy (SMA)a disease that takes away a person's ability to walk, eat, or breathe. It is the number one genetic cause of death for infants. Since 1984, we've directed and invested in comprehensive research that has shaped the scientific community's understanding of SMA. We are currently on the verge of breakthroughs in treatment that will strengthen our children's bodies, extend life, and lead to a cure. We have deep expertise in every aspect of SMAfrom the day-to-day realities to the nuances of care optionsand until we have a cure, well do everything we can to support children and families affected by the disease. Cure SMA is a non-profit organization which has funded and directed over $75 million for leading SMA research programs. We have 34 Chapters throughout the United States and over 115,000 members and supporters. We also host the world's largest Annual SMA Conference with over 1,500 families and researchers from around the world in attendance. Learn more about how you can help us reach a treatment and cure at www.cureSMA.org.

keywords:Biotechnology,Healthcare,Pharmaceuticals

123

Number of Employees

$12.1M

Revenue (est)

1

Current Jobs

31%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Chicago Youth C...
N/A1194%
YWCA Metropolit...
N/A16910%
American Red Cr...
N/A5610%
Marillac St. Vi...
N/A1049%
The Salvation A...
N/A1038%
Northern Illino...
N/A1080%
Quad Cities Cha...
$7.2M4011%
Pioneer Center ...
N/A1324%
National Insura...
N/A2554%
Polaris Charter...
N/A3210%

Cure SMA News

09/03/2019 - Cure SMA Webinar Gives Update on Zolgensma Access, Data ...

Cure SMA hosted a recent webinar with representatives from the FDA and AveXis — the company that originally developed Zolgensma, now ...

09/08/2019 - Cytokinetics and Cure SMA Renew Their Partnership

The biopharmaceutical company Cytokinetics and the nonprofit organization Cure SMA have announced a renewal of their partnership.

09/03/2019 - Cytokinetics and Cure SMA Renew Partnership to Advance ...

27, 2019 (GLOBE NEWSWIRE) -- Cure SMA and Cytokinetics (Nasdaq:CYTK) today announced the renewal of their partnership to increase ...